Ostatné · SOLV
Solventum Corporation
Fundamenty firmy Healthcare · Medical Instruments & Supplies · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 13 hodnotení
–
- Najnižší cieľ
- 70,00
- Priemerný cieľ
- 93,92
- Najvyšší cieľ
- 113,00
- Potenciál
- +6,6 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | 1,35 | 1,29–1,43 | 1,50 | −9,7 % |
| budúci štvrťrok | 1,79 | 1,74–1,90 | 1,57 | +14,0 % |
| tento rok | 7,14 | 6,55–7,55 | 6,11 | +16,9 % |
| budúci rok | 7,23 | 6,46–7,50 | 7,14 | +1,2 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 1,9 mld. | 2,1 mld. | −7,6 % |
| budúci štvrťrok | 2,1 mld. | 2,0 mld. | +4,6 % |
| tento rok | 8,2 mld. | 8,3 mld. | −1,1 % |
| budúci rok | 8,5 mld. | 8,2 mld. | +3,6 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Hanson Bryan CraigChief Executive Officer | iná transakcia | – | 01.09. |
| Harrington Paul SOfficer | iná transakcia | – | 13.05. |
| Mcmillan Wayde DChief Financial Officer | iná transakcia | – | 13.05. |
| Hanson Bryan CraigChief Executive Officer | iná transakcia | – | 13.05. |
| Kirberger Marcela A.Officer | iná transakcia | – | 13.05. |
| Gomez Tammy LOfficer | iná transakcia | – | 13.05. |
| Landucci AmyChief Technology Officer | iná transakcia | – | 13.05. |
| Wilcox Mary TOfficer | iná transakcia | – | 13.05. |
| Wendell Amy McbrideDirector | iná transakcia | – | 30.04. |
| Weiland John HDirector | iná transakcia | – | 30.04. |
| Cox Carrie SmithDirector | iná transakcia | – | 30.04. |
| May Karen JDirector | iná transakcia | – | 30.04. |
Kto vlastní akcie
Slávni investori: Nelson Peltz · 15.0 % Ray Dalio · 0.1 %
Independent Franchise Partners, LLP9,50 %
Blackrock Inc.5,73 %
Vanguard Capital Management LLC5,65 %
Trian Fund Management, LP4,84 %
Vanguard Portfolio Management LLC3,72 %
Davis Selected Advisers3,71 %
State Street Corporation3,31 %
Geode Capital Management, LLC2,88 %
O firme (popis z Yahoo Finance, anglicky)
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou SOLV.